Dr Allen M Khademi, MD | |
1 Diamond Hill Rd, Berkeley Heights, NJ 07922-2104 | |
(908) 277-8897 | |
(908) 277-8901 |
Full Name | Dr Allen M Khademi |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 32 Years |
Location | 1 Diamond Hill Rd, Berkeley Heights, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427070077 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | MA07115200 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Valley Home Care Inc. | Paramus, NJ | Home health agency |
Christian Health Care Center | Wyckoff, NJ | Nursing home |
Entity Name | Summit Medical Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
Before the federal rule was advanced, the policies put in place by various states allowed employers room to manuever, The Washington Post reports. Meanwhile, the insurance industry fears it may be left holding the bag for this requirement, and the New York Times explores the market share of Catholic hospitals.
The discovery of how the activities of the protein p53 initiate signals that trigger cell suicide offers critical insights for developing new anti-cancer drugs, according to investigators from St. Jude Children's Research Hospital.
For a long time, doctors and scientists have suspected that Neisseria lactamica, a harmless germ carried mostly by children under the age of five years, is the key to the development of natural immunity to meningococcal meningitis and septicaemia (blood poisoning).
› Verified 6 days ago
Entity Name | Christian Health Care Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427047232 PECOS PAC ID: 7618887340 Enrollment ID: O20040426000168 |
News Archive
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
Before the federal rule was advanced, the policies put in place by various states allowed employers room to manuever, The Washington Post reports. Meanwhile, the insurance industry fears it may be left holding the bag for this requirement, and the New York Times explores the market share of Catholic hospitals.
The discovery of how the activities of the protein p53 initiate signals that trigger cell suicide offers critical insights for developing new anti-cancer drugs, according to investigators from St. Jude Children's Research Hospital.
For a long time, doctors and scientists have suspected that Neisseria lactamica, a harmless germ carried mostly by children under the age of five years, is the key to the development of natural immunity to meningococcal meningitis and septicaemia (blood poisoning).
› Verified 6 days ago
Entity Name | Restorative Rehab Consultants Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952861700 PECOS PAC ID: 7012259740 Enrollment ID: O20190430001091 |
News Archive
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
Before the federal rule was advanced, the policies put in place by various states allowed employers room to manuever, The Washington Post reports. Meanwhile, the insurance industry fears it may be left holding the bag for this requirement, and the New York Times explores the market share of Catholic hospitals.
The discovery of how the activities of the protein p53 initiate signals that trigger cell suicide offers critical insights for developing new anti-cancer drugs, according to investigators from St. Jude Children's Research Hospital.
For a long time, doctors and scientists have suspected that Neisseria lactamica, a harmless germ carried mostly by children under the age of five years, is the key to the development of natural immunity to meningococcal meningitis and septicaemia (blood poisoning).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Allen M Khademi, MD 850 S 5th St, Allentown, PA 18103-3308 Ph: (610) 776-3305 | Dr Allen M Khademi, MD 1 Diamond Hill Rd, Berkeley Heights, NJ 07922-2104 Ph: (908) 277-8897 |
News Archive
OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.
Before the federal rule was advanced, the policies put in place by various states allowed employers room to manuever, The Washington Post reports. Meanwhile, the insurance industry fears it may be left holding the bag for this requirement, and the New York Times explores the market share of Catholic hospitals.
The discovery of how the activities of the protein p53 initiate signals that trigger cell suicide offers critical insights for developing new anti-cancer drugs, according to investigators from St. Jude Children's Research Hospital.
For a long time, doctors and scientists have suspected that Neisseria lactamica, a harmless germ carried mostly by children under the age of five years, is the key to the development of natural immunity to meningococcal meningitis and septicaemia (blood poisoning).
› Verified 6 days ago
Dr. Brian Freed, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8897 Fax: 908-277-8901 | |
Dr. Rohit M Oza, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300 Fax: 908-673-7132 | |
Bridgette Shallcross, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 245 Spring Ridge Dr, Berkeley Heights, NJ 07922 Phone: 908-868-3621 |